Delivery Order SPE2DB25D3021-SPE2DB25FQYRY
Award Date 6/9/25
Potential Completion Date 6/10/25
Potential Value $9.3K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $12,785.44 to AmerisourceBergen Drug Corp for the supply of Sprycel 100 mg tablets (30-count) on August 22, 2025, with an ultimate completion date of August 25, 2025. This firm fixed price, non-set-aside contract is classified as a delivery order and will be performed at the contractor's location in Conshohocken, Pennsylvania. Sprycel is a targeted cancer therapy medication, reflecting the Defense Logistics Agency's ongoing...
- The Defense Logistics Agency awarded a delivery order valued at $11,013.24 to AmerisourceBergen Drug Corp for the supply of Sprycel 100 mg tablets (30-count packaging) on June 9, 2025, with a completion date of June 10, 2025. This firm fixed-price, non-set-aside delivery order was issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a ceiling value of $999,999,999.00 and extends through December 2026. The...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $11,667.58 to AmerisourceBergen Drug Corp for the supply of Sprycel 50 mg tablets (60-count units). This competitively awarded, firm fixed-price delivery order was issued on May 19, 2025, with an ultimate completion date of May 20, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Sprycel is a targeted cancer therapy medication, and this delivery order represents a...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Sprycel 140mg tablets (30-count packages) valued at $11,140.74. This non-competitive, firm fixed-price delivery order is scheduled for completion by October 9, 2025, with performance at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $11,156.18 to AmerisourceBergen Drug Corp for Sprycel 50 mg tablets (quantity: 60 units) on August 27, 2025, with an ultimate completion date of August 28, 2025. This firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical...
- The Defense Logistics Agency awarded a delivery order valued at $5,578.09 to AmerisourceBergen Drug Corp for Sprycel 50 mg tablets (60-count) on July 25, 2025, with an ultimate completion date of July 28, 2025. This firm fixed-price contract represents a non-competitive delivery order issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 comprehensive pharmaceutical supply vehicle running through December 2026. The...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Sprycel 100 mg tablets (30-count) on September 29, 2025, with a contract ceiling value of $36,224.42 and ultimate completion date of September 30, 2025. This competitively awarded, firm fixed-price delivery order represents a non-set-aside procurement and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $10,387.97 to AmerisourceBergen Drug Corp for Sprycel 100 mg tablets (30-count) on May 5, 2025, with completion expected by May 6, 2025. This firm fixed-price, competitively awarded delivery order represents a routine pharmaceutical supply transaction under the company's existing contract vehicle with DLA. The award carries no set-aside designation and is being performed at AmerisourceBergen's Conshohocken, Pennsylvania...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $5,964.90 to AmerisourceBergen Drug Corp for Sprycel 100 mg tablets (30-count units) on July 17, 2025, with completion scheduled for July 18, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Sprycel 140mg tablets (30-count units) with a ceiling value of $11,140.74. This firm fixed-price delivery order, which carries an ultimate completion date of August 14, 2025, represents a non-competitive, non-set-aside award and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major...